NBRMAP-DB: ANTI-DIABETIC HERBAL FORMULATION

• Polyherbal anti-diabetic composition jointly developed by CSIR-NBRI & CSIR-CIMAP, Lucknow.
• Hypoglycemic in nature confirmed through Glucose tolerance test.
• Scientifically validated by in vitro and in vivo streptozotocin-induced diabetes in rat model. Significant DPP-4 inhibitor activity.
• Clinical trial done at Banaras Hindu University, Varanasi.
• Safety and toxicity parameters conformed as per OECD guidelines.
• IPR Status: Patent no. 354536.